Subretinal injection techniques for retinal disease: a review

C Irigoyen, A Amenabar Alonso… - Journal of clinical …, 2022 - mdpi.com
Inherited retinal dystrophies (IRDs) affect an estimated 1 in every 2000 people, this
corresponding to nearly 2 million cases worldwide. Currently, 270 genes have been …

[HTML][HTML] Evidence-based guidelines for drug dosing in intravitreal injections in silicone oil-filled eyes: Pharmacokinetics, safety, and optimal dosage

LF Desideri, PY Sim, E Bernardi, K Paschon… - Survey of …, 2025 - Elsevier
We evaluate the pharmacokinetics, safety, and optimal dosages of intravitreal agents in
silicone oil (SO)-filled eyes, addressing challenges in administering such therapies. We …

[Retracted] Mesenchymal Stem Cell Exosomal miR‐146a Mediates the Regulation of the TLR4/MyD88/NF‐κB Signaling Pathway in Inflammation due to Diabetic …

C Gu, H Zhang, S Zhao, D He… - … Mathematical Methods in …, 2022 - Wiley Online Library
Diabetic retinopathy (DR) is the main cause of vision loss in diabetic patients, which cannot
be completely resolved by typical blood sugar control. Inflammation influences the …

[HTML][HTML] Exposure to Silicone Oil Endotamponades Induces VEGF Antibody Aggregation and Loss of Functionality

S Wohlfart, J Herth, MB Böhmann… - … & Visual Science, 2024 - tvst.arvojournals.org
Purpose: To investigate the interaction of a common monoclonal antibody (bevacizumab)
with silicone oils and vitreous substitute hydrogels. Methods: Protein content …

Systematic review of the efficacy and safety of stage I or II IOL implantation in patients with diabetic retinopathy

B Meng, S Li, K Wang, Y Huang, Y Wang, L Zhao - Medicine, 2022 - journals.lww.com
Background: Intraocular lens (IOL) implantation is required after vitrectomy combined with
cataract surgery in diabetic retinopathy patients. However, the question of whether an IOL …